Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Top Changes At Bayer And Novartis As Vasella Goes, Reinhardt Returns

Jan 28 2013

• By John Davis

Related Content

Bayer’s Reinhardt Returning To Novartis To Replace Departing Vasella

Jan 23 2013

AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later

Jan 16 2013

Actelion And Bayer Hope Novel Drugs Can Take Over The Pulmonary Hypertension Market

Oct 29 2012

Radiotherapeutics Market Snapshot: This Sector Is Getting Hot

Dec 03 2012

Novartis Cements Chiron Buy With Increased Bid

Apr 03 2006

Bayer Prices <em>Stivarga </em>With Crowded Colon Cancer Market In Mind

Sep 27 2012

With 100% Alcon Ownership, Novartis Forms New Eye Care Unit

Dec 15 2010

Related Companies

Novartis AG

Bayer AG

AstraZeneca PLC

Roche Holding AG

Novartis AG

Novartis AG

Daiichi Sankyo Co., Ltd.

Algeta ASA

Additional Topics

Germany Europe Switzerland Business Strategies Leadership OTC Drugs BioPharmaceutical Consumer

More from Germany

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window